UTAH MEDICAL PRODUCTS INC (UTMD)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Sales, net | 9,953 | 9,710 | 10,005 | 10,400 |
| Cost of goods sold | 4,358 | 4,172 | 4,203 | 4,147 |
| Gross profit | 5,595 | 5,538 | 5,802 | 6,253 |
| Selling, general and administrative | 2,264 | 2,231 | 2,287 | 2,560 |
| Research & development | 135 | 154 | 172 | 255 |
| Total operating expenses | 2,399 | 2,385 | 2,459 | 2,815 |
| Operating income | 3,196 | 3,153 | 3,343 | 3,438 |
| Other income | 640 | 705 | 836 | 773 |
| Income before provision for income taxes | 3,836 | 3,858 | 4,179 | 4,211 |
| Provision for income taxes | 788 | 817 | 616 | 758 |
| Net income | 3,048 | 3,041 | 3,563 | 3,453 |
| Foreign currency translation net of taxes of 0 in all periods | 1,828 | 718 | 1,432 | -33 |
| Total comprehensive income | 4,876 | 3,759 | 4,995 | 3,420 |
| Earnings per common share (diluted) | 0.94 | 0.92 | 1.02 | 0.98 |
| Earnings per share, basic | 0.94 | 0.92 | 1.02 | 0.98 |
| Shares outstanding - basic | 3,246,000 | 3,310,000 | 3,478,000 | 3,532,000 |
| Shares outstanding - diluted | 3,246,000 | 3,310,000 | 3,478,000 | 3,532,000 |